199 related articles for article (PubMed ID: 23933266)
21. The impact of calcineurin inhibitors on graft survival.
Rush D
Transplant Rev (Orlando); 2013 Jul; 27(3):93-5. PubMed ID: 23743217
[TBL] [Abstract][Full Text] [Related]
22. Long-term evaluation of cyclosporine and tacrolimus based immunosuppression in pediatric liver transplantation.
Hasenbein W; Albani J; Englert C; Spehr A; Grabhorn E; Kemper MJ; Burdelski M; Ganschow R
Pediatr Transplant; 2006 Dec; 10(8):938-42. PubMed ID: 17096762
[TBL] [Abstract][Full Text] [Related]
23. Safety of belatacept bridging immunosuppression in hepatitis C-positive liver transplant recipients with renal dysfunction.
LaMattina JC; Jason MP; Hanish SI; Ottmann SE; Klassen DK; Potosky D; Hutson WR; Barth RN
Transplantation; 2014 Jan; 97(2):133-7. PubMed ID: 24342980
[TBL] [Abstract][Full Text] [Related]
24. The effect of long-term calcineurin inhibitor therapy on renal function in children after liver transplantation.
Arora-Gupta N; Davies P; McKiernan P; Kelly DA
Pediatr Transplant; 2004 Apr; 8(2):145-50. PubMed ID: 15049794
[TBL] [Abstract][Full Text] [Related]
25. Long-term outcomes of calcineurin inhibitor withdrawal for post-liver transplant renal dysfunction.
Mackay AJ; Angus PW; Gow PJ
Transplant Proc; 2011 Dec; 43(10):3802-6. PubMed ID: 22172850
[TBL] [Abstract][Full Text] [Related]
26. Emerging drugs for prevention of T-cell mediated rejection in liver and kidney transplantation.
Wong TC; Lo CM; Fung JY
Expert Opin Emerg Drugs; 2017 Jun; 22(2):123-136. PubMed ID: 28503959
[TBL] [Abstract][Full Text] [Related]
27. The efficacy and safety of mammalian target of rapamycin inhibitors ab initio after liver transplantation without corticosteroids or induction therapy.
Manzia TM; Angelico R; Toti L; Belardi C; Cillis A; Quaranta C; Tariciotti L; Katari R; Mogul A; Sforza D; Orlando G; Tisone G
Dig Liver Dis; 2016 Mar; 48(3):315-20. PubMed ID: 26682720
[TBL] [Abstract][Full Text] [Related]
28. A Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Tacrolimus and Corticosteroids in Combination With or Without Mycophenolate Mofetil in Liver Transplantation Recipients Infected With Hepatitis B Virus.
Park JI; Song GW; Ryu JH; Choi ST; Choi NG; Jung BH; Chu CW; Kim KK; Jung DH; Ha TY; Moon DB; Yang K; Shin MH; Chung YK; Hwang S; Yoon YI; Lee SG
Transplant Proc; 2023 Mar; 55(2):387-395. PubMed ID: 36822884
[TBL] [Abstract][Full Text] [Related]
29. Recipient interleukin-28B Rs12979860 C/T polymorphism and acute cellular rejection after liver transplantation: role of the calcineurin inhibitor used.
Bitetto D; Fabris C; Falleti E; Fornasiere E; Avellini C; Cmet S; Cussigh A; Fontanini E; Pirisi M; Corradini SG; Merli M; Molinaro A; Toniutto P
Transplantation; 2012 May; 93(10):1038-44. PubMed ID: 22495472
[TBL] [Abstract][Full Text] [Related]
30. Selection and use of immunosuppressive therapies after liver transplantation: current German practice.
Herzer K; Strassburg CP; Braun F; Engelmann C; Guba M; Lehner F; Nadalin S; Pascher A; Scherer MN; Schnitzbauer AA; Zimmermann T; Nashan B; Sterneck M
Clin Transplant; 2016 May; 30(5):487-501. PubMed ID: 26855333
[TBL] [Abstract][Full Text] [Related]
31. From immunosuppression to tolerance.
Adams DH; Sanchez-Fueyo A; Samuel D
J Hepatol; 2015 Apr; 62(1 Suppl):S170-85. PubMed ID: 25920086
[TBL] [Abstract][Full Text] [Related]
32. Revisiting chronic rejection following living donor liver transplantation in the tacrolimus era: A single center experience.
Choudhary NS; Saraf N; Saigal S; Gautam D; Rastogi A; Goja S; Bhangui P; Srinivasan T; Yadav SK; Soin A
Clin Transplant; 2018 Feb; 32(2):. PubMed ID: 29160909
[TBL] [Abstract][Full Text] [Related]
33. Longterm calcineurin inhibitor therapy and brain function in patients after liver transplantation.
Pflugrad H; Schrader AK; Tryc AB; Ding X; Lanfermann H; Jäckel E; Schrem H; Beneke J; Barg-Hock H; Klempnauer J; Weissenborn K
Liver Transpl; 2018 Jan; 24(1):56-66. PubMed ID: 29156491
[TBL] [Abstract][Full Text] [Related]
34. Immunosuppression minimization is safe and associated with good long-term success in pediatric recipients of liver transplant.
Chapin CA; Whitehead B; Shakhin V; Taylor SA; Kriegermeier A; Mohammad S; Alonso EM
Liver Transpl; 2024 Jul; 30(7):707-716. PubMed ID: 37934051
[TBL] [Abstract][Full Text] [Related]
35. Immunosuppression, Compliance, and Tolerance After Orthotopic Liver Transplantation: State of the Art.
Zorzetti N; Lauro A; Khouzam S; Marino IR
Exp Clin Transplant; 2022 Mar; 20(Suppl 1):3-9. PubMed ID: 35384800
[TBL] [Abstract][Full Text] [Related]
36. Tacrolimus and cyclosporin doses and blood levels in hepatitis C and alcoholic liver disease patients after liver transplantation.
Oo YH; Dudley T; Nightingale P; Haydon G; Mutimer D
Liver Transpl; 2008 Jan; 14(1):81-7. PubMed ID: 18161844
[TBL] [Abstract][Full Text] [Related]
37. Short-term outcomes of paediatric liver transplant recipients after transition to Adult Healthcare Service.
Ferrarese A; Germani G; Lazzaro S; Cananzi M; Russo FP; Senzolo M; Gambato M; Zanetto A; Cillo U; Gringeri E; Perilongo G; Burra P
Liver Int; 2018 Jul; 38(7):1316-1321. PubMed ID: 29205755
[TBL] [Abstract][Full Text] [Related]
38. Monitoring of miR-181a-5p and miR-155-5p Plasmatic Expression as Prognostic Biomarkers for Acute and Subclinical Rejection in
Millán O; Ruiz P; Orts L; Ferré P; Crespo G; Santana M; Fortuna V; Quintairos L; Navasa M; Brunet M
Front Immunol; 2019; 10():873. PubMed ID: 31068943
[No Abstract] [Full Text] [Related]
39. An update on liver transplantation: A critical review.
Neuberger J
J Autoimmun; 2016 Jan; 66():51-9. PubMed ID: 26350881
[TBL] [Abstract][Full Text] [Related]
40. Is there such a thing as protocol immunosuppression in liver transplantation?
McCaughan GW; Sze KC; Strasser SI
Expert Rev Gastroenterol Hepatol; 2015 Jan; 9(1):1-4. PubMed ID: 25164689
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
